Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Colorectal Neoplasms (Phase 2)
Hypoxia (Phase 1/Phase 2)
Hypoxia-Inducible Factor 1 (Phase 1/Phase 2)
Kidney Diseases (Phase 2)
Kidney Neoplasms (Phase 2)
Neoplasms (Phase 2)
Neoplasms by Site (Phase 2)
Neoplasms, Glandular and Epithelial (Phase 2)
Sarcoma, Clear Cell (Phase 1/Phase 2)
Urogenital Neoplasms (Phase 2)
Urologic Diseases (Phase 2)
Urologic Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue